XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Noncontrolling Interest [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 26,835 $ 106,501,396 $ (2,157,226) $ (90,014,500) $ 14,356,505
Beginning balance, shares at Dec. 31, 2020 26,834,709          
Stock-based compensation 326,164 326,164
Restricted common stock grant $ 450 (450)
Restricted common stock grant, shares 450,000          
Restricted common stock forfeitures $ (8) 8
Restricted common stock forfeitures, shares (7,500)          
Issuance of common stock through registered direct offering at $3.095 per share and accompanying warrants (net of offering expenses and placement agent discount) $ 2,800 6,726,200 6,729,000
Issuance of common stock through registered direct offering at $3.095 per share and accompanying warrants (net of offering expenses and placement agent discount), shares 2,800,000          
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount) $ 3,250 6,614,350 6,617,600
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount), shares 3,250,000          
Exercise of pre-funded common stock purchase warrants at $3.095 per share $ 7,200 22,276,800 22,284,000
Exercise of pre-funded common stock purchase warrants at $3.095 per share, shares 7,200,000          
Exercise of pre-funded common stock purchase warrants at $2.80 per share $ 11,050 30,928,950 30,940,000
Exercise of pre-funded common stock purchase warrants at $2.80 per share, shares 11,050,000          
Issuance of pre-funded common stock purchase warrants in connection with the registered direct offerings (1,817,548) (1,817,548)
Issuance of common stock purchase warrants at exercise price of $3.25 per share in connection with the registered direct offerings (49,398,510) (49,398,510)
Net income (loss) 21,721,858 21,721,858
Ending balance, value at Mar. 31, 2021 $ 51,577 122,157,360 (2,157,226) (68,292,642) 51,759,069
Ending balance, shares at Mar. 31, 2021 51,577,209          
Beginning balance, value at Dec. 31, 2020 $ 26,835 106,501,396 (2,157,226) (90,014,500) 14,356,505
Beginning balance, shares at Dec. 31, 2020 26,834,709          
Net income (loss)           16,339,371
Ending balance, value at Jun. 30, 2021 $ 51,577 122,487,573 (2,157,226) (73,675,129) 46,706,795
Ending balance, shares at Jun. 30, 2021 51,577,209          
Beginning balance, value at Mar. 31, 2021 $ 51,577 122,157,360 (2,157,226) (68,292,642) 51,759,069
Beginning balance, shares at Mar. 31, 2021 51,577,209          
Stock-based compensation 330,213 330,213
Net income (loss) (5,382,487) (5,382,487)
Ending balance, value at Jun. 30, 2021 $ 51,577 122,487,573 (2,157,226) (73,675,129) 46,706,795
Ending balance, shares at Jun. 30, 2021 51,577,209          
Beginning balance, value at Dec. 31, 2021 $ 50,904 124,426,379 56,453 (68,670,497) 55,863,239
Beginning balance, shares at Dec. 31, 2021 50,904,391          
Stock-based compensation 394,749 394,749
Restricted common stock grant $ 715 (715)
Restricted common stock grant, shares 715,000          
Restricted common stock forfeitures $ (15) 15
Restricted common stock forfeitures, shares (15,000)          
Net income (loss) (98,094) (6,600,148) (6,698,242)
Repurchase and cancellation of common stock $ (1,876) (2,061,892) (2,063,768)
Repurchase and cancellation of common stock, shares (1,876,034)          
Distribution to noncontrolling interest in consolidated subsidiary (15,692) (15,692)
Ending balance, value at Mar. 31, 2022 $ 49,728 124,820,428 (57,333) (77,332,537) 47,480,286
Ending balance, shares at Mar. 31, 2022 49,728,357          
Beginning balance, value at Dec. 31, 2021 $ 50,904 124,426,379 56,453 (68,670,497) 55,863,239
Beginning balance, shares at Dec. 31, 2021 50,904,391          
Restricted common stock forfeitures, shares (50,000)          
Net income (loss)           (7,380,430)
Repurchase and cancellation of common stock, shares (1,849,952)          
Ending balance, value at Jun. 30, 2022 $ 47,828 125,202,080 325,993 (80,358,955) 45,216,946
Ending balance, shares at Jun. 30, 2022 47,828,405          
Beginning balance, value at Mar. 31, 2022 $ 49,728 124,820,428 (57,333) (77,332,537) 47,480,286
Beginning balance, shares at Mar. 31, 2022 49,728,357          
Stock-based compensation 381,602 381,602
Restricted common stock forfeitures (50) 50
Net income (loss) 383,326 (1,065,513) (682,187)
Repurchase and cancellation of common stock (1,850) (1,960,905) (1,962,755)
Ending balance, value at Jun. 30, 2022 $ 47,828 $ 125,202,080 $ 325,993 $ (80,358,955) $ 45,216,946
Ending balance, shares at Jun. 30, 2022 47,828,405